COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif (RLO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02377323
Recruitment Status : Completed
First Posted : March 3, 2015
Last Update Posted : May 24, 2017
EMD Serono Canada Inc.
Information provided by (Responsible Party):
Pierre Duquette, Centre hospitalier de l'Université de Montréal (CHUM)

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2015
Actual Study Completion Date : December 2016
Beatty WW, Hames KA, Blanco CR, et al. Demographic, clinical and cognitive characteristics of multiple sclerosis patients who continue to work. J Neurol Rehab 1995; 9:167-73.